VTR Stock Chart & Stats
$1668.90
$0.00(0.00%)
At close: 4:00 PM EDT
$1668.90
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1,190.01 - $1,808.39
Previous CloseN/A
Volume0.00
Average Volume (3M)35.00
Market Cap
$792.36B
Enterprise Value$57.52K
Total Cash (Recent Filing)$198.96M
Total Debt (Recent Filing)$13.65B
Price to Earnings (P/E)157.6
Beta-0.15
Next Earnings
Oct 29, 2026EPS Estimate
2.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.55
Shares Outstanding512,946,350
10 Day Avg. Volume105
30 Day Avg. Volume35
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)2.81
Price to Sales (P/S)6.04
P/FCF Ratio26.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,720.79Price Target Upside3.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)10.11
Revenue Forecast (FY)$119.10B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationVentas generates substantial and rising operating and free cash flow, providing a durable funding base for dividends, reinvestment, and debt management. Cash flow that materially exceeds accounting earnings also gives the company flexibility to pursue healthcare real estate opportunities through changing market conditions.
Senior Housing Operating MomentumImproving occupancy, revenue per occupied unit, and same-store NOI indicate strengthening demand across Ventas’ senior housing platform. These operating gains can support recurring internal growth, expand property-level margins, and improve earnings power as occupancy continues recovering.
Raised Growth Investment PlanThe larger senior housing investment program expands Ventas’ exposure to a core aging-related demand category while adding assets under underwriting targets management describes as attractive. Scale, acquisition experience, and expected yields could compound portfolio cash flows over several quarters.
Bears Say
Elevated LeverageMeaningful leverage reduces financial flexibility for a defensive real estate company, particularly if property fundamentals weaken or financing conditions remain challenging. Debt obligations can constrain capital allocation, increase sensitivity to funding costs, and limit the capacity to absorb prolonged operating pressure.
Earnings-quality VolatilityThe inconsistent relationship between revenue and gross profit makes reported profitability harder to interpret and reduces confidence in margin durability. Even with improved net income and strong EBITDA margins, recurring charges or cost volatility may make future earnings less predictable.
Competitive Asset Pricing PressureGreater competition for healthcare real estate can make acquisitions less accretive by compressing yields and raising purchase prices. This pressure may limit the returns available from Ventas’ expanded investment program, requiring disciplined underwriting and increasing execution demands.
Ventas News
VTR FAQ
What was Ventas’s price range in the past 12 months?
Ventas lowest stock price was $1190.01 and its highest was $1808.39 in the past 12 months.
What is Ventas’s market cap?
Ventas’s market cap is $792.36B.
When is Ventas’s upcoming earnings report date?
Ventas’s upcoming earnings report date is Oct 29, 2026 which is in 40 days.
How were Ventas’s earnings last quarter?
Ventas released its earnings results on Jul 29, 2026. The company reported $2.381 earnings per share for the quarter, missing the consensus estimate of $2.415 by -$0.034.
Is Ventas overvalued?
According to Wall Street analysts Ventas’s price is currently Undervalued.
Does Ventas pay dividends?
Ventas does not currently pay dividends.
What is Ventas’s EPS estimate?
Ventas’s EPS estimate is 2.7.
How many shares outstanding does Ventas have?
Ventas has 512,946,350 shares outstanding.
What happened to Ventas’s price movement after its last earnings report?
Ventas reported an EPS of $2.381 in its last earnings report, missing expectations of $2.415. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ventas?
Currently, no hedge funds are holding shares in MX:VTR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ventas Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1,720.79 (3.11% Upside)
$1,720.79 (3.11% Upside)
Blogger Sentiment
Bullish
MX:VTR Sentiment 78%
Sector Average 63%
Sector Average 63%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.80%
12-Months-Change
Fundamentals
Return on Equity
2.21%
Trailing 12-Months
Asset Growth
12.02%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ventas
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.
VTR Company Deck
VTR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong operating momentum driven by senior housing: robust same‑store NOI (10% total, 16% SHOP), occupancy gains (300 bps+), revenue and margin expansion, and an upgraded investment plan to $4.5B for 2026. Balance sheet metrics improved (net debt/EBITDA 4.7x, $4.9B liquidity) and FFO guidance was raised. Challenges noted include interest rate/FX headwinds, development economics that currently do not pencil, competitive market pricing, and some non‑core asset recycling. On balance, positive operational execution, upgraded guidance, and an active accretive investment program materially outweigh the listed challenges.View all MX:VTR earnings summariesVTR Revenue Breakdown
73.30% SHOP
15.39% OM&R
10.31% NNN
1.00% Non-Segment
VTR Stock 12 Month Forecast
Average Price Target
$1,720.79
▲(3.11% Upside)
Technical Analysis
Healthpeak Properties
―
Welltower
―
Omega Healthcare
―
Healthcare Realty Trust
―
CareTrust REIT
―